Grant✓ Small businesses may apply
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of Health
- Opportunity #
- PA-25-253
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.399, 93.393
- Status
- posted
- Posted
- Nov 12, 2024
- Closes
- Sep 7, 2028
- Funding instrument
- Grant
- Category
- Education, Health
- Cost sharing required
- No
Who can apply
- •Private institutions of higher education
- •Public housing authorities/Indian housing authorities
- •Special district governments
- •Native American tribal governments (Federally recognized)
- •State governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •City or township governments
- •County governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Independent school districts
- •Small businesses
- •For profit organizations other than small businesses
- •Public and State controlled institutions of higher education
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Synopsis
This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical).
Contact
National Institutes of Health · grantsinfo@nih.gov